tiprankstipranks
Advertisement
Advertisement
Corbus Pharmaceuticals Updates Executive Employment Agreements and Protections
PremiumCompany AnnouncementsCorbus Pharmaceuticals Updates Executive Employment Agreements and Protections
23d ago
Corbus Advances CANYON-1 Phase 1b Obesity Trial Milestone
Premium
Company Announcements
Corbus Advances CANYON-1 Phase 1b Obesity Trial Milestone
25d ago
Corbus Pharmaceuticals announces last person enrolled in CANYON-1 trial
Premium
The Fly
Corbus Pharmaceuticals announces last person enrolled in CANYON-1 trial
25d ago
Corbus Pharmaceuticals files $300M mixed securities shelf
PremiumThe FlyCorbus Pharmaceuticals files $300M mixed securities shelf
2M ago
Corbus Pharmaceuticals price target raised to $57 from $53 at Oppenheimer
Premium
The Fly
Corbus Pharmaceuticals price target raised to $57 from $53 at Oppenheimer
2M ago
Corbus Pharmaceuticals: Advancing Best-in-Class Nectin-4 ADC and Emerging Obesity Franchise Support Buy Rating
Premium
Ratings
Corbus Pharmaceuticals: Advancing Best-in-Class Nectin-4 ADC and Emerging Obesity Franchise Support Buy Rating
2M ago
Corbus Advances Early-Stage Obesity Drug CRB-913: What Investors Should Watch Now
PremiumCompany AnnouncementsCorbus Advances Early-Stage Obesity Drug CRB-913: What Investors Should Watch Now
4M ago
Corbus Updates Corporate Outlook, Highlights Diversified 2026 Pipeline
Premium
Company Announcements
Corbus Updates Corporate Outlook, Highlights Diversified 2026 Pipeline
4M ago
Corbus Pharmaceuticals Announces Retirement of Board Member Holmer
Premium
Company Announcements
Corbus Pharmaceuticals Announces Retirement of Board Member Holmer
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100